FKBPs (FK506-binding proteins) belong to a distinct class of immunophilins that interact with immunosuppressants, such as FK506 and Rapamycin. FKBPs use their peptidyl-prolyl isomerase (PPIase) activity to catalyze the cis-trans conversion of prolyl bonds in proteins during protein-folding events. FKBPs also act as a unique group of chaperones. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.
FKBPs, through interactions with steroid hormone receptors, kinases, or other cellular factors, play important roles in various physiological processes and, more interestingly, in pathological processes in mammals. Mammalian FKBPs can be divided into four groups: cytoplasmic, TPR domain, endoplasmic reticulum (ER) or secretory pathway and nuclear. The cytoplasmic FKBP isoforms FKBP12 and 12.6 and the nuclear FKBP25 and 133 contain a single PPIase domain. FKBP36, 38, 51 and 52 contain multiple TPR domains. The ER FKBPs: FKBP13, 19, 22, 23, 60 and 65 all contain an N-terminal ER signal peptide.
AP20187 (B/B Homodimerizer) 是一种细胞渗透性分子,可通过使 FK506 结合蛋白 (FKBP) 二聚化来启动生物信号传导级联反应和基因表达,或破坏蛋白-蛋白之间的相互作用。
Shield-1 (Shld1) 是一种特异性、细胞可渗透、高亲和力的 FK506 结合蛋白-12 (FKBP) 配体,它通过与突变的 FKBP (mtFKBP) 结合来逆转其不稳定性,从而允许 mtFKBP 融合蛋白的条件性表达,并能稳定带有突变 FKBP12 衍生不稳定结构域的标记蛋白质。
Shield-2 是一种高效的稳定性配体,能以 29 nM 的解离常数与 FKBP (F36V) 蛋白结合,并通过紧密结合于 FKBP 突变体的不稳定域来防止其降解,从而实现对细胞内蛋白质水平的小分子调节。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号